Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 100
Titolo Data di pubblicazione Autore(i) File
Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations 1-gen-2017 Bagnasco, Diego; Ferrando, Matteo; Caminati, Marco; Bragantini, Alice; Puggioni, Francesca; Varricchi, Gilda; Passalacqua, Giovanni; Canonica, Giorgio
The North-Western Italian experience with anti IL-5 therapy amd comparison with regulatory trials 1-gen-2018 Bagnasco, Diego; Milanese, Manlio; Rolla, Giovanni; Lombardi, Carlo; Bucca, Caterina; Heffler, Enrico; Canonica, Giorgio Walter; Passalacqua, Giovanni
Anti-IL-5 and IL-5Ra: Efficacy and safety of new therapeutic strategies in severe uncontrolled asthma 1-gen-2018 Bagnasco, Diego; Caminati, Marco; Ferrando, Matteo; Aloè, Teresita; Testino, Elisa; Canonica, Giorgio Walter; Passalacqua, Giovanni
Personalizing the approach to asthma treatment 1-gen-2018 Ferrando, M.; Bagnasco, D.; Heffler, E.; Paoletti, G.; Passalacqua, G.; Puggioni, F.; Canonica, G. W.
Type 2 immunity in asthma 1-gen-2018 Caminati, M.; Pham, D. L.; Bagnasco, D.; Canonica, G. W.
Current insights in allergen immunotherapy 1-gen-2018 Passalacqua, Giovanni; Bagnasco, Diego; Ferrando, Matteo; Heffler, Enrico; Puggioni, Francesca; Canonica, Giorgio Walter
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life 1-gen-2019 Lombardi, Carlo; Bagnasco, Diego; Caruso, Cristiano; D'Amato, Mariella; Menzella, Francesco; Milanese, Manlio; Senna, Gianenrico; Canonica, Giorgio Walter; Passalacqua, Giovanni
Real-life studies of biologics used in asthma patients: key differences and similarities to trials 1-gen-2019 Heffler, E.; Paoletti, G.; Giorgis, V.; Puggioni, F.; Racca, F.; Del Giacco, S.; Bagnasco, D.; Caruso, C.; Brussino, L.; Rolla, G.; Canonica, G. W.
Strategies to reduce corticosteroid-related adverse events in asthma 1-gen-2019 Heffler, E; Bagnasco, D; Canonica, Gw
Efficacy and steroid-sparing effect of benralizumab: Has it an advantage over its competitors? 1-gen-2019 Menzella, F; Biava, M; Bagnasco, D; Galeone, C; Simonazzi, A; Ruggiero, P; Facciolongo, N
Reduction of oral corticosteroids in patients with severe eosinophilic asthma treated with Benralizumab: could it represent a marker of treatment efficacy? 1-gen-2019 Menzella, F; Latorre, M; Ruggiero, P; Bagnasco, D; Heffler, E.
30 Years Of Sublingual Immunotherapy 1-gen-2019 Passalacqua, Giovanni; Bagnasco, Diego; Canonica, Giorgio Walter
Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation 1-gen-2019 Bagnasco, Diego; Menzella, Francesco; Caminati, Marco; Caruso, Cristiano; Guida, Giuseppe; Bonavia, Marco; Riccio, Annamaria; Milanese, Manlio; Manfredi, Andrea; Senna, Gianenrico; Passalacqua, Giovanni
When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation 1-gen-2019 Bagnasco, D; Aloe', Teresita; Sclifo', Francesca; Ferrantino, M G; Marugo, F; Arcadipane, F; Manfredi, A; Canonica, G W; Passalacqua, G
One year of mepolizumab. Efficacy and safety in real-life in Italy 1-gen-2019 Bagnasco, D.; Caminati, M.; Menzella, F.; Milanese, M.; Rolla, G.; Lombardi, C.; Bucca, C.; Heffler, E.; Paoletti, Guido; Testino, E.; Manfredi, A.; Caruso, Chiara; Guida, Giangiacomo; Senna, G.; Bonavia, M.; Riccio, A. M.; Canonica, G. W.; Passalacqua, G.
Efficacy and safety of honeybee and wasp tyrosine-adsorbed venom immunotherapy 1-gen-2019 Severino, M.; Simioni, L.; Bonadonna, P.; Cantone, R.; Cortellini, G.; Crescioli, S.; D'Angelo, A.; La Rosa, L.; Macchia, D.; Martignago, I.; Massolo, A.; Reccardini, F.; Bagnasco, D.; Passalacqua, G.
Comparing a fixed combination of budesonide/formoterol with other inhaled corticosteroid plus long-acting beta-agonist combinations in patients with chronic obstructive pulmonary disease: a review 1-gen-2019 Solidoro, P; Patrucco, F; Bagnasco, D.
Pharmacokinetics and pharmacodynamics of monoclonal antibodies for asthma treatment 1-gen-2019 Bagnasco, Diego; Heffler, Enrico; Testino, Elisa; Passalacqua, Giovanni; Canonica, Giorgio Walter
Strategies to reduce corticosteroid-related adverse events in asthma 1-gen-2019 Heffler, E.; Bagnasco, D.; Canonica, G. W.
A case of chronic eosinophilic pneumonia in a patient treated with dupilumab 1-gen-2019 Menzella, F.; Montanari, G.; Patricelli, G.; Cavazza, A.; Galeone, C.; Ruggiero, P.; Bagnasco, D.; Facciolongo, N.
Mostrati risultati da 21 a 40 di 100
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile